Co-Authors
This is a "connection" page, showing publications co-authored by BARRY W FEIG and MIGUEL A RODRIGUEZ-BIGAS.
Connection Strength
1.656
-
Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014 Jun; 109(7):652-8.
Score: 0.118
-
Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
Score: 0.106
-
Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg. 2010 Feb; 251(2):261-4.
Score: 0.089
-
Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol. 2010 Feb; 17(2):441-7.
Score: 0.087
-
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):824-30.
Score: 0.085
-
Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol. 2008 Nov 10; 26(32):5254-60.
Score: 0.081
-
Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic rectal cancer: a patterns of care study from the national cancer data base. Ann Surg Oncol. 2008 Nov; 15(11):3036-47.
Score: 0.081
-
Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007 Aug; 246(2):215-21.
Score: 0.075
-
Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol. 2007 Jun; 14(6):1870-7.
Score: 0.073
-
Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol. 2007 Feb; 14(2):478-83.
Score: 0.071
-
Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1098-105.
Score: 0.062
-
A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer. 2004 May 15; 100(10):2104-9.
Score: 0.060
-
Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer. 2017 04 01; 123(7):1124-1133.
Score: 0.035
-
DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol. 2016 09 01; 34(25):3039-46.
Score: 0.035
-
Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg. 2016 May; 103(6):753-762.
Score: 0.034
-
Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 2015 May; 150(5):402-9.
Score: 0.032
-
Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surg. 2015 Mar 01; 150(3):245-51.
Score: 0.032
-
Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74.
Score: 0.031
-
Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis. J Gastrointest Surg. 2015 Jan; 19(1):180-8; discussio 188.
Score: 0.031
-
Impact of ileostomy-related complications on the multidisciplinary treatment of rectal cancer. Ann Surg Oncol. 2014 Feb; 21(2):507-12.
Score: 0.029
-
A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013 Aug; 148(8):769-77.
Score: 0.028
-
Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2013 Feb; 56(2):135-41.
Score: 0.027
-
Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum. 2012 Dec; 55(12):1213-9.
Score: 0.027
-
Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012 May 20; 30(15):1770-6.
Score: 0.026
-
Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012 Sep; 19(9):2814-21.
Score: 0.026
-
Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer. 2011 Aug 15; 117(16):3713-22.
Score: 0.024
-
Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol. 2010 Nov; 17(11):2863-9.
Score: 0.023
-
Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):60-5.
Score: 0.022
-
Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):818-23.
Score: 0.021
-
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1175-80.
Score: 0.019
-
Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol. 2008 Jan; 15(1):46-51.
Score: 0.019
-
Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007 May 01; 109(9):1750-5.
Score: 0.018
-
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):762-71.
Score: 0.018
-
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 2006 Dec 01; 66(5):1378-83.
Score: 0.018
-
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006 Jun; 29(3):219-24.
Score: 0.017
-
Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival? Am J Clin Oncol. 2006 Jun; 29(3):232-9.
Score: 0.017
-
Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum. 2006 Feb; 49(2):175-82.
Score: 0.017
-
Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg. 2004 Jan; 8(1):56-62; discussion 62-3.
Score: 0.015
-
Chemoradiation for adenocarcinoma of the anus. Int J Radiat Oncol Biol Phys. 2003 Mar 01; 55(3):669-78.
Score: 0.014
-
Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer. 2003 Jan 15; 97(2):517-24.
Score: 0.014